BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36066207)

  • 1. Insights about circadian clock in glioma: From molecular pathways to therapeutic drugs.
    Wang Z; Chen G
    CNS Neurosci Ther; 2022 Dec; 28(12):1930-1941. PubMed ID: 36066207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy.
    Chai R; Liao M; Ou L; Tang Q; Liang Y; Li N; Huang W; Wang X; Zheng K; Wang S
    Biomed Res Int; 2022; 2022():9774879. PubMed ID: 35832846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
    Chang WH; Lai AG
    J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation.
    Wang Z; Su G; Dai Z; Meng M; Zhang H; Fan F; Liu Z; Zhang L; Weygant N; He F; Fang N; Zhang L; Cheng Q
    Cell Prolif; 2021 Mar; 54(3):e12988. PubMed ID: 33442944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian regulation of cancer cell and tumor microenvironment crosstalk.
    Xuan W; Khan F; James CD; Heimberger AB; Lesniak MS; Chen P
    Trends Cell Biol; 2021 Nov; 31(11):940-950. PubMed ID: 34272133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronically alternating light-dark cycles on circadian clock mediated expression of cancer (glioma)-related genes in the brain.
    Khan S; Liu Y; Siddique R; Nabi G; Xue M; Hou H
    Int J Biol Sci; 2019; 15(9):1816-1834. PubMed ID: 31523185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of circadian clock genes with the hallmarks of cancer.
    Ortega-Campos SM; Verdugo-Sivianes EM; Amiama-Roig A; Blanco JR; Carnero A
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188900. PubMed ID: 37105413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacological strategies focused on chrono-drug discovery.
    Ohdo S; Koyanagi S; Matsunaga N
    Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian rhythm in prostate cancer: time to take notice of the clock.
    Zhu WZ; He QY; Feng DC; Wei Q; Yang L
    Asian J Androl; 2023; 25(2):184-191. PubMed ID: 36073562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
    Wang F; Luo Y; Li C; Chen L
    Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian clock and cell cycle: Cancer and chronotherapy.
    Yao J; He C; Zhao W; Hu N; Long D
    Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian clock as a possible control point in colorectal cancer progression (Review).
    Rao X; Lin L
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It's About Time: Advances in Understanding the Circadian Regulation of DNA Damage and Repair in Carcinogenesis and Cancer Treatment Outcomes.
    Ashok Kumar PV; Dakup PP; Sarkar S; Modasia JB; Motzner MS; Gaddameedhi S
    Yale J Biol Med; 2019 Jun; 92(2):305-316. PubMed ID: 31249491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro RNAs and the biological clock: a target for diseases associated with a loss of circadian regulation.
    Ma Q; Mo G; Tan Y
    Afr Health Sci; 2020 Dec; 20(4):1887-1894. PubMed ID: 34394254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma.
    Liang Y; Wang S; Huang X; Chai R; Tang Q; Yang R; Huang X; Wang X; Zheng K
    Comput Math Methods Med; 2021; 2021():8238833. PubMed ID: 34745328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian clock, carcinogenesis, chronochemotherapy connections.
    Yang Y; Lindsey-Boltz LA; Vaughn CM; Selby CP; Cao X; Liu Z; Hsu DS; Sancar A
    J Biol Chem; 2021 Sep; 297(3):101068. PubMed ID: 34375638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapy in Glioblastoma: state of the art and future perspectives.
    Petković M; Henis M; Heese O; Relógio A
    EBioMedicine; 2023 Mar; 89():104470. PubMed ID: 36796229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of the clock genes in gliomas.
    Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
    Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy.
    Zhu H; Chen J; Wen Z; Li J; Yu Q; Liao W; Luo X
    Life Sci; 2023 Nov; 333():122145. PubMed ID: 37797685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of circadian clock gene and association with cancer pathophysiology.
    Keshvari M; Nejadtaghi M; Hosseini-Beheshti F; Rastqar A; Patel N
    Chronobiol Int; 2020 Feb; 37(2):151-175. PubMed ID: 31791146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.